C17 research network
The C17 Research Network operates under the auspices of the C17 Council, a non-profit organization that represents the 16 academic pediatric oncology/hematology programs in the 17 centres across Canada. The network is set up to encourage and develop collaborative, multi-disciplinary, multi-site, Canadian research in pediatric hematology, oncology and hematological stem cell transplantation in furthering C17’s mission to improve health outcomes and quality of life for children and adolescents in Canada with cancer and blood disorders.
C17 Research Operating Grant Competition
The C17 Research Network holds an annual peer-reviewed grant competition to fund projects in pediatric hematology, oncology and hematological stem cell transplantation. The grant review process ranks applications based on criteria including clear statement of research, methodology, innovativeness and originality, evidence of collaboration and multidisciplinary approach and impact or application into clinical practice. The scope of projects considered include but are not limited to: phase I, II, III and pilot clinical trials; registries and population based studies; biological sample banks; quality of life and psychosocial research; health outcomes and health serviced research; and basic laboratory and translational research.
By encouraging and funding multi-centre, multi-disciplinary research Canada wide, C17 is reducing barriers to access to research studies and thereby increasing treatment and research opportunities for all children to participate in the improving of health outcomes and the quality of life. Funding for the competition is partnered with Childhood Cancer Canada and The Kids With Cancer Society (Edmonton).
Grants provide from $45,000 to $100,000 per year. See the annual call for LOIs for current information.
C17 DVL Grant Competition
The mandate of the C17 Developmental Therapeutics (DVL) Committee is to support nationwide collaborative pre-clinical and early phase research in hematologic and oncologic diseases and hematopoietic stem cell transplantation in children. The research areas considered for this competition will be for preclinical translational grants with the potential to lead to a Phase I trial in pediatrics.
DVL grants provide up to $100,000 for one year; there no minimum value. See the annual call for LOIs for current information.
- C17 competitions are announced every year in September/November.
- Letters of Intent are due every year in November/December for the new competition.
- Full grant applications are due every April/May.
- Successful grant may receive funding in July, once a signed agreement is in place.
Round 18 (2015/16) C17 Research Grant Competition and Round 3 Ewing Sarcoma Competition
C17 Research Network priorities are to fund collaborative research that preferentially is performed in collaboration of multiple pediatric oncology/hematology centres, is multi-disciplinary in nature, and is supportive of new research collaborations and researchers. See the call for LOIs for competition details and the areas of research considered for funding in the current competition.
Guidance Documents and Application Forms
- Round 18 Call for LOIs: Operating Grant Competition
- Ewing Sarcoma Competition Announcement Round 3
- C17 LOI Application Form
- C17 Research Funding Application and Award Guide 28Jan2016
C17/Cancer Research Society Partnership
C17 has joined with the Cancer Research Society (CRS) to fund up to two basic or translational research projects in pediatric oncology at a maximum value of $60,000/year for 2 years (announced November 9, 2015). Applications in the areas of pediatric oncology basic/translational research or pre-clinical developmental therapeutics (DVL) should be directed towards this competition.
For competition details, due dates and forms go to: www.crs-src.ca/for-researchers-operating-grant
For further information on the C17 Research Network contact:
C17 Research Coordinator